Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The ACUITY Trial: A Randomized Comparison of Angiomax (Bivalirudin) Versus Heparin (Unfractionated Heparin or Enoxaparin) in Patients Undergoing Early Invasive Management for Acute Coronary Syndromes Without ST-Segment Elevation
Brief Summary: The purpose of this study is to show that, when compared with heparin (enoxaparin or unfractionated heparin) and routine GPIIb/IIIa inhibition (either started upfront or at the time of percutaneous coronary intervention \[PCI\]; Arm A):

1. Bivalirudin with routine GPIIb/IIIa inhibition (either started upfront or at the time of PCI; Arm B) provides non-inferior or superior overall clinical outcomes and
2. Bivalirudin alone (Arm C) reduces clinically significant bleeding. An important secondary objective for this comparison is to show that bivalirudin is not inferior for ischemic complications.


Options:
A: Intervention Type: DRUG; Name: Angiomax (bivalirudin) anticoagulant; Assigned to Arm(s): N/A
B: Arm Label: bare-metal stent without tirofiban; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Postfibrinolysis percutaneous coronary intervention | Arm Label: bare-metal stent with tirofiban; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Postfibrinolysis percutaneous coronary intervention | Arm Label: paclitaxel-eluting stent without tirofiban; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Postfibrinolysis percutaneous coronary intervention | Arm Label: paclitaxel-eluting stent with tirofiban; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Postfibrinolysis percutaneous coronary intervention | Intervention Type: PROCEDURE; Name: Postfibrinolysis percutaneous coronary intervention; Assigned to Arm(s): bare-metal stent without tirofiban | Intervention Type: PROCEDURE; Name: Postfibrinolysis percutaneous coronary intervention; Assigned to Arm(s): bare-metal stent with tirofiban | Intervention Type: PROCEDURE; Name: Postfibrinolysis percutaneous coronary intervention; Assigned to Arm(s): paclitaxel-eluting stent without tirofiban | Intervention Type: PROCEDURE; Name: Postfibrinolysis percutaneous coronary intervention; Assigned to Arm(s): paclitaxel-eluting stent with tirofiban
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Other: abciximab followed by implantation of bare metal stent | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Other: abciximab and Sirolimus eluting stent | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Other: tirofiban and bare metal stent | Arm Label: 4; Type: EXPERIMENTAL; Interventions: Other: tirofiban and sirolimus-eluting stent | Intervention Type: OTHER; Name: abciximab followed by implantation of bare metal stent; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: abciximab and Sirolimus eluting stent; Assigned to Arm(s): 2 | Intervention Type: OTHER; Name: tirofiban and bare metal stent; Assigned to Arm(s): 3 | Intervention Type: OTHER; Name: tirofiban and sirolimus-eluting stent; Assigned to Arm(s): 4
D: Arm Label: bare metal stent; Type: ACTIVE_COMPARATOR; Interventions: Device: Bare metal stent implantation | Arm Label: Endeavor sprint stent; Type: EXPERIMENTAL; Interventions: Device: zotarolimus eluting stent | Intervention Type: DEVICE; Name: Bare metal stent implantation; Assigned to Arm(s): bare metal stent | Intervention Type: DEVICE; Name: zotarolimus eluting stent; Assigned to Arm(s): Endeavor sprint stent

Answer: A